Interactions between Neuronal Nicotinic Acetylcholine Receptors, N-Methyl-D-Aspartate Receptors and β-amyloid in the Brain of Genetically Modified Mice

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Apolipoprotein E

  2007cited by this paper
• Preventing Alzheimer's: A Lifelong Commitment?

  2005cited by this paper
• Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis

  2005cited by this paper
• Presenilin-Dependent Transcriptional Control of the A -Degrading Enzyme Neprilysin by Intracellular Domains of APP and APLP

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-β

  2005cited by this paper
• Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies

  2005cited by this paper
• High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.

  2005cited by this paper
• Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

  2004cited by this paper
• α7‐Nicotinic acetylcholine receptors mediate an Aβ1−42‐induced increase in the level of acetylcholinesterase in primary cortical neurones

  2004cited by this paper
• Strategies for disease modification in Alzheimer's disease

  2004cited by this paper
• M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway.

  2004cited by this paper
• MAPK recruitment by β‐amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time

  2004cited by this paper
• Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease

  2004cited by this paper
• Pathways towards and away from Alzheimer's disease

  2004cited by this paper
• PET imaging of amyloid in Alzheimer's disease.

  2004cited by this paper
• Mechanism of Action of Galantamine on N-Methyl-d-Aspartate Receptors in Rat Cortical Neurons

  2004cited by this paper
• β-Sheet Breakers for Alzheimers Disease Therapy

  2004cited by this paper
• Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice

  2004cited by this paper
• Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.

  2004cited by this paper
• The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

  2004cited by this paper
• Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation.

  2004cited by this paper
• PDAPP; YFP double transgenic mice: A tool to study amyloid‐β associated changes in axonal, dendritic, and synaptic structures

  2003cited by this paper
• Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.

  2003cited by this paper
• Loss of nicotinic receptors induced by beta‐amyloid peptides in PC12 cells: Possible mechanism involving lipid peroxidation

  2003cited by this paper
• Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex.

  2003cited by this paper
• Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

  2003cited by this paper
• Current pharmacologic options for patients with Alzheimer's disease

  2003cited by this paper
• Phosphorylation of extracellular‐regulating kinase in NMDA receptor antagonist‐induced newly generated neurons in the adult rat dentate gyrus

  2003cited by this paper
• Toward an Early Diagnosis and Treatment of Alzheimer's Disease

  2003cited by this paper
• A presenilin dimer at the core of the γ-secretase enzyme: Insights from parallel analysis of Notch 1 and APP proteolysis

  2003cited by this paper
• Amyloid β1–42 peptide alters the gating of human and mouse α‐bungarotoxin‐sensitive nicotinic receptors

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes

  2003cited by this paper
• Neuronal nicotinic and muscarinic receptor subtypes at different ages of transgenic mice overexpressing human acetylcholinesterase.

  2003cited by this paper
• Memantine in moderate-to-severe Alzheimer's disease.

  2003cited by this paper
• APP processing and synaptic function.

  2003cited by this paper
• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• Inhibition of human α7 nicotinic acetylcholine receptors by open channel blockers of N‐methyl‐D‐aspartate receptors

  2003cited by this paper
• The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography

  2003cited by this paper
• Correlation of oxidative stress and the loss of the nicotinic receptor alpha 4 subunit in the temporal cortex of patients with Alzheimer's disease.

  2003cited by this paper
• Inflammation in neurodegenerative disease--a double-edged sword.

  2002cited by this paper
• A non-alpha7 nicotinic acetylcholine receptor modulates excitatory input to hippocampal CA1 interneurons.

  2002cited by this paper
• Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine.

  2002cited by this paper
• Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro.

  2002cited by this paper
• β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes*

  2002cited by this paper
• Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)

  2002cited by this paper
• Treating Alzheimer's Disease With Cholinesterase Inhibitors: What Have We Learned So Far?

  2002cited by this paper
• Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment.

  2002cited by this paper
• The role of extracellular signal-regulated kinase in cognitive and motor deficits following experimental traumatic brain injury.

  2002cited by this paper
• Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

  2002cited by this paper
• Preimplantation diagnosis for early-onset Alzheimer disease caused by V717L mutation.

  2002cited by this paper
• Memory enhancement: the search for mechanism-based drugs

  2002cited by this paper
• Selective nicotinic receptor consequences in APP(SWE) transgenic mice.

  2002cited by this paper
• Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

  2002cited by this paper
• Upregulation of neuronal nicotinic receptor subunits α4, β2, and α7 in transgenic mice overexpressing human acetylcholinesterase

  2002cited by this paper
• Therapeutic strategies for Alzheimer's disease

  2002cited by this paper
• Presenilin 1 Mutations Activate γ42-Secretase but Reciprocally Inhibit ε-Secretase Cleavage of Amyloid Precursor Protein (APP) and S3-Cleavage of Notch*

  2002cited by this paper
• The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.

  2002cited by this paper
• A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing.

  2002cited by this paper
• β‐Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

  2002cited by this paper
• Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

  2001cited by this paper
• Presenilin, Notch, and the genesis and treatment of Alzheimer's disease

  2001cited by this paper
• Characterization of a Presenilin-mediated Amyloid Precursor Protein Carboxyl-terminal Fragment γ

  2001cited by this paper
• Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

  2001cited by this paper
• A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation.

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Presenilin‐dependent γ‐secretase processing of β‐amyloid precursor protein at a site corresponding to the S3 cleavage of Notch

  2001cited by this paper
• Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity.

  2001cited by this paper
• Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein.

  2001cited by this paper
• β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons

  2001cited by this paper
• Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase

  2001cited by this paper
• NMDA receptor pharmacology: perspectives from molecular biology.

  2001cited by this paper
• The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner.

  2001cited by this paper
• β-Amyloid Activates the Mitogen-Activated Protein Kinase Cascade via Hippocampal α7 Nicotinic Acetylcholine Receptors:In Vitro and In Vivo Mechanisms Related to Alzheimer's Disease

  2001cited by this paper
• Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

  2001cited by this paper
• Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

  2001cited by this paper
• Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.

  2001cited by this paper
• Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells.

  2001cited by this paper
• β-Amyloid1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice

  2001cited by this paper
• Nicotinic receptor abnormalities in Alzheimer's disease.

  2001cited by this paper
• Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695*

  2001cited by this paper
• Secretases as targets for the treatment of Alzheimer's disease.

  2000cited by this paper
• Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

  2000cited by this paper
• CAMs and axonal growth: a critical evaluation of the role of calcium and the MAPK cascade.

  2000cited by this paper
• Neuronal nicotinic receptors in the human brain.

  2000cited by this paper
• Cholinesterase inhibitors: A new class of psychotropic compounds.

  2000cited by this paper
• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

  2000cited by this paper
• A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease

  2000cited by this paper
• Decreased Protein Levels of Nicotinic Receptor Subunits in the Hippocampus and Temporal Cortex of Patients with Alzheimer’s Disease

  2000cited by this paper
• Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates.

  2000cited by this paper
• Allosteric Modulation of Nicotinic Receptors as a Treatment Strategy for Alzheimer’s Disease

  2000cited by this paper
• Statins and the risk of dementia.

  2000cited by this paper
• Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

  2000cited by this paper
• A 5-month, randomized, placebo-controlled trial of galantamine in AD

  2000cited by this paper
• Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

  2000cited by this paper
• High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

  2000cited by this paper
• Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

  2000cited by this paper

• No citing papers are available for this paper.